Lomelí-Nieto, J. A., Muñoz-Valle, J. F., Navarro-Zarza, J. E., Baños-Hernández, C. J., Gutierrez-Brito, J. A., Renteria-Cabrera, V., . . . Hernández-Bello, J. (2024). Impact of Plasminogen Activator Inhibitor-1 Serum Levels and the -675 4G/5G Variant in the SERPINE1 Gene on Systemic Sclerosis in a Mexican Population. Life (Basel, Switzerland), 14(9), 1056. https://doi.org/10.3390/life14091056
Chicago Style (17th ed.) CitationLomelí-Nieto, José Alvaro, et al. "Impact of Plasminogen Activator Inhibitor-1 Serum Levels and the -675 4G/5G Variant in the SERPINE1 Gene on Systemic Sclerosis in a Mexican Population." Life (Basel, Switzerland) 14, no. 9 (2024): 1056. https://doi.org/10.3390/life14091056.
MLA (9th ed.) CitationLomelí-Nieto, José Alvaro, et al. "Impact of Plasminogen Activator Inhibitor-1 Serum Levels and the -675 4G/5G Variant in the SERPINE1 Gene on Systemic Sclerosis in a Mexican Population." Life (Basel, Switzerland), vol. 14, no. 9, 2024, p. 1056, https://doi.org/10.3390/life14091056.